Detection of mutant p53 using field-effect transistor biosensor.
暂无分享,去创建一个
Hong-Kun Lyu | Bong Hyun Chung | Moonil Kim | Sang Hee Han | Sang Kyu Kim | Kyoungsook Park | So Yeon Yi | Hye-Jung Park | H. Lyu | Moonil Kim | B. Chung | Sang Kyu Kim | Kyoungsook Park | Hye-Jung Park
[1] P. Fromherz,et al. A neuron-silicon junction: a Retzius cell of the leech on an insulated-gate field-effect transistor. , 1991, Science.
[2] Jang-Kyoo Shin,et al. An FET-type charge sensor for highly sensitive detection of DNA sequence. , 2004, Biosensors & bioelectronics.
[3] I. Willner,et al. An integrated NAD+-dependent enzyme-functionalized field-effect transistor (ENFET) system: development of a lactate biosensor. , 2000, Biosensors & bioelectronics.
[4] C. Harris,et al. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. , 1999, Mutation research.
[5] C. Harris,et al. The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.
[6] Hong-Kun Lyu,et al. An ISFET biosensor for the monitoring of maltose‐induced conformational changes in MBP , 2009, FEBS letters.
[7] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[8] Bong Hyun Chung,et al. Self-directed and self-oriented immobilization of antibody by protein G-DNA conjugate. , 2007, Analytical chemistry.
[9] A. Fersht,et al. Recognition of DNA by p53 core domain and location of intermolecular contacts of cooperative binding. , 2002, Journal of molecular biology.
[10] C. Stratakis,et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[11] Gang Wei,et al. Identification of two serine residues important for p53 DNA binding and protein stability , 2003, FEBS letters.
[12] C. Pabo,et al. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. , 1993, Genes & development.
[13] B Wolf,et al. Monitoring of cellular signalling and metabolism with modular sensor-technique: the PhysioControl-Microsystem (PCM). , 1998, Biosensors & bioelectronics.
[14] M. J. Deen,et al. Model for the field effect from layers of biological macromolecules on the gates of metal-oxide-semiconductor transistors , 2005 .
[15] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[16] W. Deppert,et al. Binding of MAR‐DNA elements by mutant p53: Possible implications for its oncogenic functions , 1996, Journal of cellular biochemistry.
[17] M. Schöning,et al. Recent advances in biologically sensitive field-effect transistors (BioFETs). , 2002, The Analyst.
[18] R Montesano,et al. Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.
[19] Bert Vogelstein,et al. p53 function and dysfunction , 1992, Cell.
[20] Wojciech Makalowski,et al. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features , 1999, Oncogene.
[21] G. Thomas,et al. P53 gene alterations in human tumors: perspectives for cancer control. , 1997, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[22] P. Sorger,et al. Electronic detection of DNA by its intrinsic molecular charge , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Prives,et al. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis , 1996, Molecular and cellular biology.
[24] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.